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Background: Differential diagnosis in early arthritis is challenging, especially early after
symptom onset. Several studies applied musculoskeletal ultrasound in this setting,
however, its role in helping diagnosis has yet to be clearly defined. The purpose of
this work is to systematically assess the diagnostic applications of ultrasonography in
early arthritis in order to summarize the available evidence and highlight possible gaps
in knowledge.
Methods: In December 2017, existing systematic literature reviews (SLR) on rheumatoid
arthritis (RA), osteoarthritis (OA), psoriatic arthritis (PsA), polymyalgia rheumatica (PMR),
calcium pyrophosphate deposition disease (CPPD), and gout were retrieved. Studies on
ultrasound to diagnose the target conditions and detecting elementary lesions (such as
synovitis, tenosynovitis, enthesitis, bone erosions, osteophytes) were extracted from the
SLRs. The searches of the previous reviews were updated and data from new studies
fulfilling the inclusion criteria extracted. Groups of reviewers worked separately for each
disease, when possible diagnostic accuracy (sensitivities, specificities) was calculated
from primary studies. When available, the reliability of ultrasound to detect elementary
lesions was extracted.
Results: For all the examined disease, recent SLRs were available. The new searches
identified 27 eligible articles, with 87 articles included from the previous SLRs. The
diagnostic performance of ultrasound in identifying diseases was addressed by 75
studies; in most of them, a single elementary lesion was used to define diagnosis, except
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for PMR. Only studies on RA included consecutive patients with new onset of arthritis,
while studies on gout and CPPD often focused on subjects with mono-arthritis. Most of
the remaining studies enrolled patients with a defined diagnosis. Synovitis was the most
frequently detected lesion; clinical diagnosis was the most common reference standard.
The diagnostic performance of ultrasound across different conditions was extremely
variable. Ultrasound to identify elementary lesions was assessed in 38 studies in OA,
gout and CPPD. Its performance in OA was very variable, with better results in CPPD
and gout. The reliability of ultrasound was moderate to good for most lesions.
Conclusions: Although a consistent amount of literature investigated the diagnostic
application of ultrasound, in only a minority of cases its additional value over clinical
diagnosis was tested. This SLR underlines the need for studies with a pragmatic design
to identify the placement of ultrasound in the diagnostic pathway of new-onset arthritis.
Keywords: early arthritis, ultrasonography, diagnosis, systematic review, imaging
INTRODUCTION
With effective treatment strategies for inflammatory
arthropathies becoming extensively available, in the last
decade a prompt diagnosis, allowing intervention within the
window of opportunity, has become a critical point in the
management of early arthritis (1). However, in rheumatology
diagnosis can be achieved with certainty in a minority of cases,
and this is particularly true when patients are assessed at very
early stages of diseases. While in some cases the presence of
valuable biomarkers, such as anticyclic citrullinated peptides
antibodies (ACPA), drives the diagnostic process, in seronegative
early arthritis the degree of uncertainty remains high. Moreover,
the current classification criteria for the main rheumatic diseases,
which are often inappropriately used to help diagnosis, require
differential diagnosis to be performed before they are applied
(2). This difficulty in the correct definition of diagnoses at early
stages might lead to inappropriate management, delaying the
start of effective treatment but also exposing patients to useless
and potentially toxic drugs. In addition, also in a research setting,
an imprecise diagnosis implies the impossibility to measure
reliably the effect of innovative treatments in early phases. In
this context, there is a great interest in the research of new
biomarkers and new tools to help the diagnostic process.
Musculoskeletal ultrasonography has been widely applied in
rheumatic diseases, demonstrating to be a valid and reproducible
tool in both inflammatory and non-inflammatory pathologies.
The relevance of this instrument has also been recognized
by the European League Against Rheumatism (EULAR), that
recommends ultrasound among the imaging which can be
considered to help the clinical management of several conditions
(3–5). The applications of ultrasound cover the areas of diagnosis,
assessment of prognosis, follow-up of diseases and guide for
intra-articular and peri-tendinous procedures. In the field of
diagnosis, most of the studies on ultrasound investigated the
frequency of elementary lesions characteristics of diseases, thus
providing information on the diagnostic performance of this
tool to detect single abnormalities or on the performance of
single lesions to diagnose a disease. On the other hand, only a
minority of studies tests the diagnostic value of combinations
of lesions, assessed at the same time. Moreover, in this context
elementary lesions are not selected based on their diagnostic
properties and specificity for a certain condition. Only a minority
of studies, in which the added value of ultrasound is tested
jointly with clinical evaluation (6, 7), apply a pragmatic design
that reproduces the clinical context. The lack of information
on the application of ultrasound in a realistic clinical process
of diagnosis translates into the limited weight given to this
imaging in classification criteria. For instance, the only role for
ultrasound in Rheumatoid Arthritis (RA) classification is the
possible confirmation of the presence of synovitis (2), while to
date the only classification criteria including ultrasound are those
for polymyalgia rheumatica (PMR) (8).
Given the limited availability of methodologically sound
studies to address the diagnostic performance of ultrasound in a
realistic clinical context of differential diagnosis of inflammatory
arthropathies, the Ultrasound Study Group of the Italian Society
for Rheumatology (SIR) prioritized its research on this subject.
The present study represents the first step of such project.
The aim of the present work was the evaluation of the
available literature on the diagnostic application of ultrasound in
inflammatory arthropathies.
MATERIALS AND METHODS
As a first step, the most relevant differential diagnoses
in patients with suspected inflammatory arthropathies were
identified, including also osteoarthritis (OA) as a relevant
differential diagnosis. We afterwards individuated two research
questions, rephrased following the PICOs (Patient, Intervention,
Comparator, Outcome, Study type) methodology to provide
inclusion and exclusion criteria (Table 1). On this basis, we
planned separate systematic literature reviews (SLR) to assess
the diagnostic performance of ultrasound to diagnose OA, RA,
psoriatic arthritis (PsA), PMR, gout, calcium pyrophosphate
deposition disease (CPPD). The SLRs were not registered, but
a common protocol was available for all researchers before
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TABLE 1 | Inclusion criteria for research questions.
Population Intervention Comparators (reference
standard)
Outcomes Study type
What is the added value of




Ultrasound Clinical diagnosis (without
imaging) Other imaging






What is the accuracy of
ultrasound for detecting





















the beginning of the process. The diagnostic performance of
ultrasound in detecting elementary lesions was also addressed.
If studies on diagnostic performance reported also data on
intra and inter-reader reliability on elementary lesions, that
information was also extracted. Working groups composed by
supervisors and fellows were created to work separately on each
topic, participants were selected based on the expertise on the
specific disease and on SLR methodology to create uniform
groups. The most recent SLRs on ultrasound in the same diseases
were first sought in electronic databases (5, 9–13). Some of the
authors involved in the present project were also co-authors of
these SLR and could provide background material (AA, ABa,
AI, AZ, CS, EF, GF, GS). Since many of the existing SLR had a
broader focus, only primary studies focusing on the diagnostic
use of ultrasound were taken into account for the present work.
The search strategies of the previous SLR were applied in
PubMed and Embase, starting from the date of the last search
of the previous reviews (5, 9–13). Searches were last run on
November 30th 2017. The search on PubMed and Embase was
selected because we expected that all the relevant literature would
be retrieved, and we did not expect to find further evidence
including other databases. The records retrieved from the new
searches were transferred into a bibliographic manager software
(Zotero, RRID:SCR_013784) and libraries shared with each
working group. The titles and abstracts of the retrieved records
were evaluated by pairs of reviewers to assess the eligibility for
full-text review according to the pre-specified criteria. Full-texts
were afterwards evaluated by the same criteria and data from the
included studies extracted into a standardized form, including 2
× 2 tables of diagnostic performance. A flow-chart describing
the selection process was separately generated for each SLR.
Results were summarized through summary of findings tables,
describing both studies included in the previous reviews and
those identified by the present ones.
RESULTS
In total, all search strategies retrieved 943 references since the
date of the last search of the previous SLRs. The higher number
of references belonged to the fields of PsA and gout (Additional
Online File). After reviewing the abstracts, 27 papers were finally
included, together with 87 articles from previous SLRs meeting
the inclusion criteria, for a total of 114 papers included in the
present SLR (Table 2). The PRISMA flow-chart of the SLR for
each disease is available in the Additional Online File, as well as
the full results, presented through summary of findings tables.
Ultrasound for the Clinical Diagnosis of
Inflammatory Arthropathy
Information regarding the value of ultrasound to diagnose
diseases could be extracted from 75 studies. The greatest amount
of evidence was available for PsA, with 29 studies assessing the
diagnostic performance of ultrasound.
There were meaningful differences in terms of enrolled
populations across different diseases. In fact, in studies
addressing PsA andOA, the primary aimwasmostly to report the
prevalence of different lesions. The frequency of each lesion was
compared in patients with already known PsA or OA and healthy
controls or patients with other definite diseases. A realistic
clinical scenario of consecutive patients referred for suspicion of
inflammatory arthropathy was rarely available (6).
Conversely, studies on RA evaluated the added value of
ultrasound over classification criteria (14–17), the added value
for diagnosis on top of clinical findings (18–20) or its prognostic
value over the future development of RA (21–25) by cross-
sectional or longitudinal study design.
Studies dealing with PMR mostly included populations
of consecutive patients with shoulder pain (8, 13, 26) and
some of them evaluated the additional value of ultrasound on
the diagnostic performance of the 2012 classification criteria
(8, 26, 27).
In the fields of both gout and CPPD, most of the studies
included patients presenting with mono-arthritis and with
suspect crystal-related arthritis.
Despite these discrepancies across different conditions, there
were only a few studies, mainly focused on RA, that enrolled a
population of consecutive patients with joint pain (6, 16–20, 22,
24, 28).
Frontiers in Medicine | www.frontiersin.org 3 May 2020 | Volume 7 | Article 141
Sakellariou et al. Ultrasonography for Diagnosis in Arthritis
TABLE 2 | Features of the SLRs used as a basis for the present work.
Target disease References Aim of the SLR Last searches Number of studies included in
the present SLR
RA (12) To evaluate the added value of ultrasound over clinical
findings to the diagnosis of RA in patients with
suspected arthritis
November 2015 11
OA (5) To provide evidence for the development of the EULAR
recommendations for the use of imaging for the clinical
management of OA. The SLR does not focus only on
ultrasound
December 2015 18
PsA (9) To provide evidence for the selection and design of an
observational study of the Ultrasound Study Group of the
SIR. The SLR focuses on ultrasound
September 25th 2015 24
CPPD (10) To provide evidence on the diagnostic performance of
ultrasound to diagnose CPPD and to retrieve all the
ultrasound definitions of CPPD. The SLR focuses on
ultrasound.
31 December 2014 18
PMR (13) To review the accuracy of imaging to diagnose PMR October 2nd 2013 10
Gout (11) To provide evidence on the diagnostic performance of
ultrasound to help clinicians in the choice of imaging.
The SLR does not focus only on ultrasound
February 2016 6
GRAPH 1 | Number of studies using each single elementary lesion to establish
diagnoses, alone or in combination. CPP, calcium pyrophosphate; MSU,
monosodium urate.
The interventions used to help diagnosis were also
variable. Since most of the studies did not have diagnostic
accuracy as primary objective, data on the diagnosis
of disease were based on single elementary lesions. A
relevant exception was represented by PMR, for which
some studies addressed different lesions (tenosynovitis,
bursitis and synovitis) in combination (8, 26, 27).
Graph 1 summarizes all the different lesions used to
define diagnosis.
The confirmation of the diagnosis was based on a variety of
reference standards, which depended on the diagnostic suspicion,
as expected. While clinical diagnosis was frequently considered
in RA and PMR, for PsA the confirmation of diagnosis mostly
relied on clinical diagnosis and classification criteria, while
synovial fluid analysis was frequently considered in crystal-
related arthropathies (Graph 2).
GRAPH 2 | Reference standards adopted to confirm diagnoses. PMR,
polymyalgia rheumatica; CPPD, calcium pyrophosphate deposition disease;
OA, osteoarthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SFA,
synovial fluid analysis.
The study design adopted to define diagnostic accuracy was
also widely variable. While studies aiming to diagnose RA were
mainly cohort studies (15–24, 28), in the field of PsA emerged
a significant prevalence of studies with a case-control design;
controls were represented mostly by patients with RA (29–37),
while in some studies also healthy controls were included (29,
31, 33, 38–43). For the remaining diseases, the type of study was
more variable (Graph 3).
In OA, adding ultrasound information to the clinical
evaluation increased the certainty of the diagnosis made by the
clinician (6), while the likelihood of OA, compared to being
healthy, increased with the finding of bone erosions (44).
In the field of RA, some studies supported the possibility
to integrate clinical and ultrasound findings to reclassify
undifferentiated arthritis (14–17, 21), while in other studies
ultrasound information was applied to confirm a diagnosis of RA
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or tested against a clinical diagnosis (18–20), leading in general
to an increase in diagnostic performance. The prognostic value
of ultrasound in predicting the future development of the disease
or the need for specific treatment has also been tested, once
again with positive results supporting this application (22–24, 28)
(Tables 3, 4). The most specific lesion to diagnose RA were bone
erosions, with the specificity of 1 reported by a single study (19),
although also the specificity of PD positive synovitis was high
(ranging from 0.88 to 0.93).
Despite a higher number of studies with a focus on PsA, in this
area there was a greater variability, due to many different lesions,
tissues and sites assessed. Many studies (14 studies) focused on
the assessment of entheseal abnormalities (30, 34, 35, 39, 40, 42,
45–52) and the joints (6 studies) (29, 32, 33, 38, 41, 53), while only
a few studies assessed the fingers (considering joints, tendons,
soft tissues and entheses) (31, 36, 37) or the nails (43, 54, 55).
The primary aim of the included studies rarely addressed the
diagnostic accuracy. In fact, most of the studies compared the
prevalence of lesions in PsA and other diseases. Also, for this,
the diagnostic performance of ultrasound findings, which were
usually considered alone and not in combination or in addition
to clinical findings, was extremely variable across lesions and sites
(Table 5). Among the tested lesions, those proving to be more
specific to detect PsA were those at the level of the entheses. In
fact, the specificity of entheseal PD ranged from 0.33 to 0.99, of
enthesophytes from 0.52 to 1 and of calcifications from 0.86 to
GRAPH 3 | Study design of the included studies, depending on the assessed
disease. PMR, polymyalgia rheumatica; CPPD, calcium pyrophosphate
deposition disease; OA, osteoarthritis; PsA, psoriatic arthritis; RA, rheumatoid
arthritis; SFA: synovial fluid analysis.
0.97. Peritenonitis was also very specific (from 0.95 to 1 when PD
signal was present).
Studies focusing on ultrasound of the hips and the shoulders
in PMR had a more variable design. In fact, along with some
older studies with a case-control design (8, 56–59) several cohort
studies, including that on which the current classification criteria
are based (8), included consecutive patients with shoulder pain
(34, 60). Moreover, several recent studies provided external
validation for the classification criteria (26). Again, in terms of
accuracy, studies yielded very heterogeneous results (Table 6). In
general, bilateral findings seemed to be more specific for PMR.
The specificity of bilateral subacromiodeltoid bursitis ranged
from 0.68 to 0.99, while for bilateral long head of the biceps
tenosynovitis ranged from 0.62 to 0.98.
Studies in CPPD evaluated several different sites, including
the knees (61–68), the wrist (69, 70), the affected joint or all
joints (71). Study design was variable, including both case-control
and cohort studies. The diagnosis of CPPD was confirmed more
frequently by synovial fluid analysis, while in some cases a clinical
diagnosis (70, 71) or histology (68) were used as references. In
general, ultrasound seemed to perform well in identifying this
condition, especially at the knee and the wrist. The specificity
to confirm CPPD at the knee (considering all the assessed sites)
ranged from 0.66 to 1, while at the wrist from 0.81 to 0.91.
In the field of gout, the type of joint under investigation was
widely variable, all studies (72–74) but two (75, 76) adopted
synovial fluid analysis as reference standard to diagnose the
TABLE 4 | Performance of ultrasound to predict RA by elementary lesions by site.
Sensitivity








Summary of sensitivities, specificities across studies assessing the performance of
ultrasound to predict RA by elementary lesions by site. Only Filer reports sensitivity and
sensitivity for every joint. Gray Scale and power Doppler≥ 2. MCP, Metacarpophalangeal;
PIP, Proximal interphalangeal.
TABLE 3 | Performance of ultrasound to detect RA by elementary lesions and reliability.
Lesion* Sensitivity Specificity Intra-reader kappa Inter-reader kappa
Min Max Min Max Min Max Min Max
Erosions – 0.38 – 1 – 0.93 – –
GS synovitis 0.69 0.94 0.5 0.86 0.83 0.94 0.56 0.86
PD synovitis 0.72 0.89 0.88 0.93 0.87 0.99 0.64 0.89
Summary of sensitivities, specificities and reliability across studies assessing the performance of ultrasound to diagnose RA elementary lesions. Of the 13 papers included,only four
reported sensibility-sensitivity by using gray scale (GS) and/or power Doppler (PD) ≥ 2. *Hands (including proximal interphalangeal joints) and wrists.
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TABLE 5 | Performance of ultrasound lesions to detect PsA and reproducibility.
Lesion Sensitivity Specificity Intra-reader kappa Inter-reader kappa
Min Max Min Max Min Max Min Max
Synovial hypertrophy 0.16 0.76 0 1 – – 0.78–1 –
Joint effusion 0.07 0.61 0.33 0.82 – – – –
Erosions 0.04 0.58 0.40 1 – – – –
Enthesopathy 0.22 1 0.20 1 – – – –
Entheseal PD 0.05 0.3 0.30 0.99 0.91 0.97 – –
Entheseal erosions 0.05 0.20 0.96 1 – – – –
Enthesophytes 0.15 0.55 0.52 1 – – – –
Entheseal calcifications 0.02 0.19 0.86 0.97 – – – –
Peritenonitis PD 0.36 0.65 0.95 1.00 – – – –
Peritenonitis GS 0.54 0.60 0.95 0.97 – – – –
Soft tissue oedema 0.29 0.42 0.90 1 – – – –
Bursitis 0.02 0.10 0.90 0.99 0.96 – 0.87 –
Summary of sensitivities, specificities and reliability across studies assessing the performance of ultrasound to diagnose PsA. Min, minimal; Max, maximal; PD, power Doppler; GS,
gray scale.
TABLE 6 | Performance of ultrasound lesions to detect PMR.
Lesion Sensitivity Specificity
Min Max Min Max
SAD bursitis at least monolateral 0.09 0.96 0.59 0.90
SAD bursitis bilateral 0.32 0.93 0.68 0.99
LHB tenosynovitis at least monolateral 0.14 0.81 0.47 0.59
LHB tenosynovitis bilateral 0.30 0.37 0.62 0.98
GH synovitis at least monolateral 0.20 0.77 0.34 0.78
GH synovitis bilateral 0.03 0.52 0.66 0.90
Hip synovitis at least monolateral 0.24 0.45 0.55 0.88
Hip synovitis bilateral 0.18 0.38 0.83 0.92
Trochanteric bursitis at least monolateral 0.21 0.98 0.70 0.91
Summary of sensitivities, specificities across studies assessing the performance of
ultrasound to diagnose PMR. Min, minimal; Max, maximal; SAD, subacromiodeltoid; LHB,
long head of the biceps; GH, gleno-humeral.
disease. 4/6 studies had a cross-sectional design, while the two
remaining were a prospective (73) and a retrospective (72)
study. While 4 studies reported a satisfactory performance of
ultrasound (73–75, 77), for 2 studies sensitivity was low (72,
76). Considering the combination of all possible elementary
lesions (e.g., double contour, aggregates, tophi), the specificity of
ultrasound to diagnose gout ranged from 0.42 to 0.87.
Ultrasound to Diagnose Elementary
Lesions
Data on the accuracy of ultrasound to detect elementary lesions
were extracted only for OA, CPPD and gout, with 20 (78–96), 12
(68–70, 97–104), and 6 (105–110) studies addressing this aspect,
respectively (Tables 7–10).
The typical population enrolled was represented by subjects
with confirmed disease, in which ultrasound was compared to a
reference standard to confirm the presence of a lesion.
As expected, also the reference standard was variable, in
particular for OA. For CPPD, the only assessed target lesion
was CPP deposition, which was evaluated by conventional
radiography (2 studies), synovial fluid analysis (6 studies),
microscopic analysis (2 studies). All studies on gout but one
(107), in which conventional radiography was used, adopted
synovial fluid analysis as reference standard.
Most of the studies assessing ultrasound to detect elementary
lesions had a cross-sectional design, in particular, all the studies
on OA, 4 (74–77) and 9 (62, 69, 70, 99–101, 103) studies for gout
and CPPD, respectively, while the remaining studies for these two
conditions had a cohort design.
In OA, results on the performance of ultrasound were once
again widely variable across studies. This was also due to the
variability of the reference standards adopted to define each
separate lesion and the assessment of different anatomical areas.
Most of the studies on CPPD reported good performance of
ultrasound to detect deposits, and this was true especially for
specificity. The same conclusions can be drawn from the included
articles on gout.
Reliability
Most of the studies on OA in which reliability data were
presented reported good reliability for the assessment of
osteophytes, erosions, effusion, cartilage damage, synovitis and
cysts (Table 7).
In RA, the available evidence supported a good intra-reader
and inter-reader reliability for erosions, GS and PD synovitis
across all the assessed sites (Tables 3, 4).
There was less information about reliability in the ultrasound
assessment of PsA; entheseal PD, synovial hypertrophy and
bursitis were the only lesions for which reliability was available.
Inter-reader reliability was good for synovial hypertrophy and
bursitis, as well as intra-reader for entheseal PD and bursitis
(Table 5).
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TABLE 7 | Performance of ultrasound to detect osteoarthritis elementary lesions and reliability.
Site/lesion Sensitivity Specificity Intra-reader kappa Inter-reader kappa
Min Max Min Max Min Max Min Max
Knee osteophytes
Vs CR 0.95 0.99 0.57 0.94 0.82 0.87 – –
Vs hist. 0.7 0.9 – –
Hand osteophytes
Vs CR 0.83 0.96 0.65 0.76 0.087 1 0.53 0.69
Vs MRI 0.82 0.9 0.75 0.95
Vs PE 0.89 – 0.68 –
Foot osteophytes
Vs CR 0.62 – 0.86 – – – – –
Hand JSN
Vs CR 0.82 – 0.72 – – – – –
Knee cartilage damage
Vs CR 1 – 1 – – – –
Vs hist. 0.78 0.89 – – 0.67
Hand erosions
Vs CR 0.73 0.94 0.90 1 0.81 – 0.69 0.90
Vs MRI 0.65 0.88 0.90 0.96
Knee erosions
Vs CR 0.33 – 0.99 – – – – –
Foot erosions
Vs CR 0.33 – 0.98 – – – – –
Knee effusion
Vs PE 0.74 1 0 0.52 – – – –
Vs JA 1 – 0 –
Vs MRI 0.81 – – –
Hand effusion
Vs PE 1 – – – 0.81 – 0.69 –
Vs MRI 0.92 – 0.98 –
Popliteal cyst
Vs PE 0.36 0.67 0.89 0.98 – – – –
Vs scint. 0.29 – 0.90 –
Hand cysts
Vs MRI 0.87 – 0.97 – 0.81 – 0.69 –
Hand synovitis
Vs PE 0.15 – 0.96 – 0.81 – 0.69 –
Vs MRI 0.84 – 0.96 –
Knee synovitis
Vs PE 0.67 – 0.50 – – – – –
Pes anserinus bursitis
Vs PE 0.50 – 0.96 – – – – –
Summary of sensitivities, specificities and reliability across studies assessing the performance of ultrasound to diagnose OA elementary lesions. Min, minimal; Max, maximal; CR,
conventional radiography; hist, histology; MRI, magnetic resonance imaging; PE, physical examination; JA, joint aspiration; scint, scintigraphy.
Among the included studies on PMR, none reported
information on the reliability for the assessed lesions.
For CPPD, some studies reported a good inter-reader
reliability to assess both the meniscal fibrocartilage and the
hyaline cartilage at the level of the knee (Table 8). In gout during
acute attacks, very good intra-reader reliability was reported for
double contour, aggregates, erosions and hypervascularisation.
Inter-reader reliability was assessed for tophi, erosions, double
contour, hypervascularisation and aggregates, still with good
values (Table 9). The reliability on the same lesions was also
assessed in the intercritical phases, with still good, although in
general lower, results (Table 10).
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TABLE 8 | Performance of ultrasound to detect CPPD elementary lesions and reproducibility.
Site/lesion Sensitivity Specificity Intra-reader kappa Inter-reader kappa
Min Max Min Max Min Max Min Max
Knee FC 0.007 0.96 0.50 1.00 – – 0.68 0.81
Knee HC 0.59 1.00 0.00 1.00 – – 0.55 0.81
Wrist TFCC 0.78 0.81 0.85 0.91 – – – –
Summary of sensitivities, specificities and reliability across studies assessing the performance of ultrasound to diagnose CPPD elementary lesions. FC, fibrocartilage; HC, Hyaline
Cartilage; TFCC, Triangular Fibrocartilage Complex.
TABLE 9 | Performance of ultrasound to detect gout elementary lesions and reproducibility (acute attack).
Site/lesion Sensitivity Specificity Intra-reader kappa Inter-reader kappa
Min Max Min Max Min Max Min Max
Knee/DC – 0.75 – – – – – –
Knee/tophi — 0.62 – – – – – –
1st MTP/DC 0.62 0.87 – – – – – –
1st MTP/tophi 0.71 0.87 – – – – – 0.82
1st MTP/erosion 0.52 – – – – – – 0.83
1st MTP/effusion 0.29 – – – – – – –
Knee/1st MTP erosion 0.31 0.48 0.53 0.79 – – – –
Knee/1st MTP DC 0.34 0.51 0.91 0.99 – – – 0.87
Knee/1st MTP tophi 0.21 0.65 0.96 1.0 – – 0.47 0.83
Knee/1st MTP echogenic foci 0.71 0.85 0.56 0.73 – – – –
Symptomatic joint or tendon/erosion 0.11 0.33 0.03 0.81 1.0 – 0.86 –
Symptomatic joint or tendon/hypervascularization 0.88 0.98 0.39 0.66 0.83 - 0.67 –
Symptomatic joint or tendon/HCA 0.25 0.87 0.18 0.99 0.81 – 0.58 0.71
Symptomatic joint or tendon/DC 0.36 0.52 0.83 0.96 1.0 – 0.63 0.71
Symptomatic joint or tendon/tophi 0.29 0.52 0.95 1.0 – – 0.74 –
Summary of sensitivities, specificities and reliability across studies assessing the performance of ultrasound to diagnose gouty elementary lesions (acute attack). Min, minimal; Max,
maximal; MTP, metatarsophalangeal; DC, double contour; HCA, hyperechoic cloudy area.
DISCUSSION
The aim of our SLR was that of retrieving all the available
evidence to support future studies on the integration of the
information provided by ultrasound in the diagnostic process.
Several groups had already focused on this aspect, since recent
SLRs were available for all of the conditions of our interest (5,
9, 11, 13, 104). The existing reviews presented a summary of the
diagnostic use of ultrasound deriving from a relevant number of
studies for each considered disease. Despite all the reviews being
relatively recent, we found additional studies in the subsequent
literature from which we could retrieve further evidence. The
number of SLRs and eligible studies represents a clue of the
interest that ultrasound as diagnostic tool has raised. The easier
availability of high-end ultrasound equipment, the accessibility
to training and the possibility to apply directly the information
provided by ultrasound during a routine visit are likely the
features that have driven the enthusiasm about the technique.
However, when analyzing in depth the available literature, there is
an evident gap between the interest in the diagnostic applications
of ultrasound and the quality of the studies produced so far in this
field. In fact, with some important exceptions, the main objective
of the studies was that of describing the prevalence of different
lesions and comparing groups of patients in terms of ultrasound
findings. Although information on diagnostic accuracy can be
retrieved also from such study design, these results cannot be
generalized to external populations, since a realistic clinical
setting is not reproduced.
Many studies, in fact, included patients with definite and
longstanding diagnosis and adopted a case-control design, with
controls that were unlikely to be very similar to the true
differential diagnoses of disease. This is particularly true for PsA,
for which most of the studies had a case-control design.
There was limited evidence regarding the diagnosis of OA (6),
while for RA and PMR the studies reproduced a more pragmatic
context. In fact, in RA, some studies evaluated patients with
new-onset arthralgia and tested the ability of ultrasound to help
confirm diagnosis (19), while some others integrated ultrasound
on top of classification criteria (16, 17). There were also some
studies testing the prognostic value of ultrasound on the future
development of RA (22).
In the context of PMR, some older studies still adopted a
case-control design (56), however, since the development of the
new classification criteria (8), the interest has shifted to the
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TABLE 10 | Performance of ultrasound to detect gout elementary lesions and reproducibility (intercritic phase).
Site/lesion Sensitivity Specificity Intra-reader kappa Inter-reader kappa
Min Max Min Max Min Max Min Max
Knee effusion 0.92 1.0 0.77 0.95 – – – –
Knee synovial hypertrophy 0.49 0.74 0.92 1.0 – – – –
Knee intra-articular PD 0.20 0.45 0.92 1.0 – – – –
Midtarsal joints /effusion, synovial hypertrophy, erosion, tophi 0.91 0.94 0.93 0.96 – – – –
MTP joints/effusion, synovial hypertrophy, erosion, tophi 0.90 0.95 0.78 0.85 – – – –
Multiple sites/intra-articular or intrabursal HAG 0.78 0.91 0.65 0.91 – 0.67 0.50 0.54
Tendon/ligament HAG 0.55 0.72 0.84 0.95 – 0.67 0.50 0.54
Tendon/hyperechoic linear band 0.47 0.64 0.65 0.91 – 0.70 0.35 0.36
Cartilage/DC 0.66 0.82 0.76 0.89 – 0.88 0.69 0.74
1st MTP erosion 0.51 0.77 0.84 0.98 – – 0.29 0.74
1st MTP DC 0.53 0.84 0.59 1.0 – – 0.37 0.61
1st MTP tophi 0.26 0.77 0.88 1.0 – – 0.26 0.78
1st MTP effusion 0.09 0.30 0.51 0.77 – – 0.23 0.60
1st MTP synovial hypertrophy 0.03 0.19 0.92 1.0 – – 0.36 0.81
1st MTP synovitis 0.01 0.14 0.73 0.93 – – 0.48 0.83
Summary of sensitivities, specificities and reliability across studies assessing the performance of ultrasound to diagnose gouty elementary lesions (intercritic phase). Min, minimal; Max,
maximal; PD, power Doppler; MTP, metatarsophalangeal; DC, double contour; HAG, hyperechoic aggregate.
evaluation of the additional impact of ultrasound on classification
(26). The performance of US in this context was highly variable.
Such heterogeneous results might be due to the disease, which
may present with variable abnormalities, thus affecting the US
sensitivity. Bilateral pathologic conditions appear to be the most
specific US findings.
In the field of crystal-related arthropathies, several studies
evaluated both patients during the acute presentation and
the inter-critical periods. The population of interest was
that of patients presenting with monoarthritis, representing a
realistic clinical scenario for this diagnostic suspicion, although
quite specific.
The ability of ultrasound to correctly identify elementary
lesions typical of each disease seemed to be good, and this was
especially true for inflammatory lesions. When a suboptimal
performance was achieved, it must be kept in mind that in several
studies the reference standard adopted to define a lesion (e.g.,
physical examination) could not be considered the optimal one
for the specific lesion.
Although this was not the primary objective of this SLR,
we extracted information on intra and inter-reader reliability, if
available. The information from the primary studies supported
good reliability of ultrasound to identify inflammatory lesions,
as well as signs of damage, at the level of joints and entheses,
as well as deposition of crystals. It must however be considered
that rheumatologists taking part in ultrasound studies might have
greater expertise on a specific lesion or disease than average, so
that such reliabilities could not be reproduced in a clinical setting.
The present SLR has some limitations. First, only two
databases were searched, and, although probably the greatest part
of the literature has been covered, we cannot exclude the presence
of further studies, even among gray literature. Due to the clinical
heterogeneity of the results, we did not perform a pooled estimate
of the diagnostic performance. Moreover, a formal assessment
of quality and risk of bias was not performed. However, the
present work is, to our knowledge, the first one to provide a
comprehensive overview on the diagnostic use of ultrasound
in arthritis, with a focus on the general question and without
concentrating on a single disease.
What emerges from the overview of the results of our SLR
is that a very few studies (6, 16, 19, 22, 24) investigated the
additional impact of ultrasound findings in making a diagnosis
in consecutive patients presenting with joint symptoms, which is
indeed the typical scenario of every day’s rheumatologist work.
In most studies, clinical and ultrasound assessments were
performed separately, and ultrasound findings were not
evaluated on top of clinical findings but validated against
clinical diagnosis. With this being almost the only evidence
available today, it is of no surprise that so far, the relevance
of ultrasound in recommendations on the diagnosis and
management of rheumatic diseases and in classification criteria
is so limited. This happens despite ultrasound being an ideal
tool in this context: adequate ultrasound equipment can now
be easily accessible, they can be used during scheduled visits
and provide immediately helpful information. Multiple sites
can be assessed at the same time with good acceptability by
the patients. Several other modern imaging have been applied
in the setting of early arthritis, such as magnetic resonance
imaging (MRI), positron emission tomography (PET) od dual
energy CT (DECT), however they present a limited feasibility
compared to ultrasound, limited availability, higher costs and,
in some cases, limited data in the clinical setting. Since the
accuracy of ultrasound in detecting elementary lesions has
been established and the increasing ultrasound expertise across
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rheumatologists allows at least some findings to be detected
reliably, the time has come to test the real potentialities of
ultrasound during the first evaluation for the suspicion of
inflammatory arthropathy. The Musculoskeletal ultrasound
Study Group of the Italian Society for Rheumatology has
recently focused on the design of such study, which implies
the definition of the ideal combination of joints to be assessed
based on the clinical suspicion and confirming diagnoses
after a follow-up. Before the application of ultrasound, an
initial set of differential diagnoses should be defined for each
patient, based on clinical features. The additional value of an
ultrasound examination, targeted on the clinical suspicion,
would afterwards be tested in terms of correct and timely
diagnosis. We expect that these results will help clarify the
real role of ultrasound through the process of diagnosis and
help giving a new insight into its correct placement in the
management of inflammatory arthropathies.
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